Your browser doesn't support javascript.
loading
Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease.
Soudy, Rania; Patel, Aarti; Fu, Wen; Kaur, Kamaljit; MacTavish, David; Westaway, David; Davey, Rachel; Zajac, Jeffrey; Jhamandas, Jack.
Afiliação
  • Soudy R; Department of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Patel A; Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Fu W; Department of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Kaur K; Department of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
  • MacTavish D; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
  • Westaway D; Chapman University School of Pharmacy, Irvine, California, USA.
  • Davey R; Department of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Zajac J; Department of Medicine (Neurology), Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Jhamandas J; Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Alzheimers Dement (N Y) ; 3(1): 44-56, 2017 Jan.
Article em En | MEDLINE | ID: mdl-29067318

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Alzheimers Dement (N Y) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Alzheimers Dement (N Y) Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Canadá